Autonomic Dysfunction Impairs Baroreflex Function in an Alzheimer's Disease Animal Model

Area of Science:

• Neuroscience
• Cardiovascular Physiology
• Autonomic Nervous System Research

Background:

• Alzheimer's disease (AD) patients often experience orthostatic hypotension, a condition characterized by an inability to adequately increase blood pressure upon standing.
• This physiological challenge in AD increases the risk of serious cardiovascular events, including stroke.

Purpose of the Study:

• To investigate the underlying autonomic nervous system mechanisms contributing to orthostatic hypotension in a rat model of Alzheimer's disease (STZ-AD).
• To elucidate the baroreflex dysfunction associated with AD pathology.

Main Methods:

• Utilized the streptozotocin-induced rat model of Alzheimer's disease (STZ-AD).
• Assessed baroreflex responses, including blood pressure and heart rate, via femoral catheterization in anesthetized rats.
• Measured autonomic activity using specific pharmacological blockers and splanchnic sympathetic nerve recordings.
• Quantified autonomic receptor expression in cardiac tissue using Western blot analysis.

Main Results:

• STZ-AD rats exhibited a blunted heart rate response to hypotension and reduced maximal sympathetic nerve activity, indicating impaired sympathetic function.
• Parasympathetic nerve activity, assessed via heart rate response to hypertension, remained unchanged.
• Autonomic blockade revealed an elevated baseline sympathetic tone in STZ-AD rats.
• Cardiac expression of beta-1 adrenergic and M2 muscarinic acetylcholine receptors did not differ between STZ-AD and control rats.

Conclusions:

• This research provides the initial evidence linking Alzheimer's disease pathology to significant alterations in baroreflex function, primarily impacting the sympathetic nervous system.
• The observed sympathetic dysfunction in the STZ-AD model offers potential mechanistic explanations for orthostatic hypotension observed in human AD patients.